Huffines Discussion fostering healthy dialogue through event

Dr. Noah Dean delivers his speech, Avoiding Gimmicks in Health and Fitness, Friday at the Huffines Discussion at Rudder Theatre.

People are often told that the key to a successful performance is focusing, but the real stickler is focusing on the right thing, said Jacques Dallaire, an exercise physiology expert who works with professional athletes and entertainers who want to be the best in their business.

"The issue is not focusing harder," he said. "It's focusing correctly."

Dallaire was one of eight speakers Friday at the second annual Huffines Discussion who gave 15-minute presentations on their expertise in the field of sports medicine.

The event was organized by the Texas A&M Huffines Institute for Sports Medicine and Human Performance, a group aiming to connect exercise scientists, practitioners and the public in hopes of increasing health.

Giving an example of when focusing can be used the wrong way, Dallaire pointed to basketball players who miss shots because they're thinking about the previous shot they missed.

"If you want the results to be as good as possible, stop thinking about the results," he said. "Be the boss of your own mind. Choose to exercise that control and direct your focus correctly."

Topics weren't just limited to sports and sports medicine, but appealed to anyone with a general interest in health or fitness and were meant to help people in their everyday lives, said Tim Lightfoot, a professor of kinesiology and institute director.

Wendy Kohrt, a professor of medicine at the University of Colorado, gave advice about keeping bones strong to prevent osteoporosis -- a condition typically diagnosed in older people who have lost bone density, causing their bones to become weak and easily fractured.

Read this article:
Huffines Discussion fostering healthy dialogue through event

Huffines Institute fostering healthy dialogue through event

Dr. Noah Dean delivers his speech, Avoiding Gimmicks in Health and Fitness, Friday at the Huffines Discussion at Rudder Theatre.

People are often told that the key to a successful performance is focusing, but the real stickler is focusing on the right thing, said Jacques Dallaire, an exercise physiology expert who works with professional athletes and entertainers who want to be the best in their business.

"The issue is not focusing harder," he said. "It's focusing correctly."

Dallaire was one of eight speakers Friday at the second annual Huffines Discussion who gave 15-minute presentations on their expertise in the field of sports medicine.

The event was organized by the Texas A&M Huffines Institute for Sports Medicine and Human Performance, a group aiming to connect exercise scientists, practitioners and the public in hopes of increasing health.

Giving an example of when focusing can be used the wrong way, Dallaire pointed to basketball players who miss shots because they're thinking about the previous shot they missed.

"If you want the results to be as good as possible, stop thinking about the results," he said. "Be the boss of your own mind. Choose to exercise that control and direct your focus correctly."

Topics weren't just limited to sports and sports medicine, but appealed to anyone with a general interest in health or fitness and were meant to help people in their everyday lives, said Tim Lightfoot, a professor of kinesiology and institute director.

Wendy Kohrt, a professor of medicine at the University of Colorado, gave advice about keeping bones strong to prevent osteoporosis -- a condition typically diagnosed in older people who have lost bone density, causing their bones to become weak and easily fractured.

Follow this link:
Huffines Institute fostering healthy dialogue through event

My Nutrition – Biggest Loser SlimCoach

Here is what the main screen for the interface looks like. You can easily get to any day you've used the system for, and see these stats for any day.

So in this case I had a shake for breakfast, a salad with lemonade for lunch, and an omelet with water for dinner. This is a nice mix of pre-made items and personal recipes to demonstrate how the system works.

For pre-made items like the shake, you search their system to find the entry. The system has thousands of items in it and has pretty much anything pre-made. So I found this and selected it. Easy. Now it's one of my 'favorites' so I can easily add it in going forward without searching for it.

For the salad and omelet, I added those as recipes. Adding a recipe is also easy. You make your list of ingredients and it already knows the calories in, for example, grape tomatoes. So you just tell it the quantity and it does the rest. You can save those recipes and even share them with others. And again it then is easy to select them going forward.

Once you've gone that, it shows you all the carbs, protein, fat, and calories, and even other values like sodium and vitamin A, on these easy to use screens. So you can scan your menu and see what is good and what might need to be adjusted. You can see how you're doing for calorie count and carb count.

I definitely like the My Nutrition area of the SlimCoach system, and find it quite useful. No matter what your weight and health desires, it's good to know what you're ingesting and how it's affecting you!

My one minor complaint here is that it shows all the top numbers in red if they're below whatever level you set. So say I set my carbohydrate level to be 25% of my daily intake of calories. I want to stay below 25%. So a low number is GOOD. However, the system shows it as red. I should be able to indicate that I think low numbers are good in some areas.

Buy the Biggest Loser Slimcoach White from Amazon.com Buy the Biggest Loser Slimcoach Black from Amazon.com

Continue reading here:
My Nutrition - Biggest Loser SlimCoach

Pride of the Pine Belt: Sacks Outdoors

HATTIESBURG, MS (WDAM) -

Longevity is often intangible for businesses these days, but Sacks Outdoors in downtown Hattiesburg has made it through 61 years and is still going strong.

Forjust as many yearsbusinesses have come and gone in downtown Hattiesburg.

"The changes were meant to be I guess. People trying to find other sources other ways of making themselves feel new," said owner of Sacks Outdoors, David Sackler.

Sackler says he and his family never wanted to move the business anywhere else.

"I always thought downtown was the place for me," said Sackler.

That dedication is exactly why the Historic Hattiesburg Downtown Association made Sackler the recipient of the inaugural "Making It Happen" award.

Sackler was born in Poland, and his family relocated to Mississippi in 1948. In 1951 Sackler's father started the family operation.

"It was spread from just aclothing store to a sporting good store. Now we have a variety of other items," said Sackler.

Now, a third generation of the Sackler familyhas taken over. David's son Aaron .

Continued here:
Pride of the Pine Belt: Sacks Outdoors

County Reaches Tentative Deal With Firefighters Union

Posted: Mar. 23, 2012 | 3:39 p.m.

Clark County firefighters reached a tentative three-year contract agreement with county officials Friday afternoon that is expected to save the county about $60 million over 25 years.

The deal, which runs from July 1, 2012, to June 30, 2015, eliminates longevity pay for new hires, where county staff members expect to reap most of the savings, and freezes cost of living adjustments for the first two years with the option of allowing either party to renegotiate the third year.

County officials have said they spend about $25 million a year on overall longevity pay, originally used as a recruitment tool to attract employees and reward them annually for their years of service after eight years.

According to the most recent annual employee compensation report, longevity pay made up about 8 percent of firefighter pay and 15 percent of battalion chief pay.

The report also showed that fire payroll has decreased by more than $11.3 million, 12 percent, over the past two years because of collective bargaining concessions and operational changes. County officials also reported the average salary and benefits for firefighters falling to $175,000 in fiscal year 2011 from $189,000 in fiscal year 2010.

"The Local 1908 has come to the table and demonstrated a sincere willingness to address the short- and long-term financial issues the county faces," Assistant County Manager Ed Finger said. "There have been some past challenges, but their assistance and partnership is real and deserves recognition."

Union members are slated to vote on the agreement April 10-12. The County Commission is expected to ratify the agreement at its April 17 meeting.

"It's a great deal for both sides," said Ryan Beaman, president of the International Association of Firefighters Local 1908. "We were responsive to county and taxpayer needs. When both sides come to the table and negotiate, and are open and willing to work together, the negotiations process works."

Beaman added that firefighters have taken a 10.5 percent decrease in pay over the past two years.

Read the rest here:
County Reaches Tentative Deal With Firefighters Union

People in the News: Hulin Wu; Kris Vanhercke; Kevin Fickenscher

University of Rochester Medical Center said this week that Hulin Wu, a professor of biostatistics and computational biology, will serve as the founding director of its newly established Center for Integrative Bioinformatics and Experimental Mathematics.

The new center is part of the university's department of biostatistics and computational biology and will work on integrating and strengthening current biostatistics, bioinformatics, and computational biology resources at the center. The school hopes to develop a strong interdisciplinary research program and attract external funding, in particular large center grants and program grants in bioinformatics, computational biology and systems biology. It also plans to establish a PhD/MS education program in bioinformatics and computational biology

Initially, the center will serve researchers conducting basic science experiments, clinical studies, and translational research in immunology and infectious diseases. It also hopes to develop techniques and approaches to manage, analyze, and extract meaningful information from biomedical data.

Biogazelle, a real-time PCR data analysis company, has tapped Kris Vanhercke to serve as its chief operating officer.

Prior to joining Biogazelle, Vanhercke held a number of positions within Roche Diagnostics with the most recent being sales director for Roche Diagnostics Belgian office. He also held a scientific sales position at Boehringer Mannheim.

The American Medical Informatics Association has tapped Kevin Fickenscher as president and CEO of the organization.

Fickenscher will officially start his new role on April 1. He replaces Ted Shortliffe, who announced his decision to step down from the position several months ago.

Here is the original post:
People in the News: Hulin Wu; Kris Vanhercke; Kevin Fickenscher

NHLBI to Fund Collaborative Systems Biology Disease Studies

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) Because complex diseases can result from multiple perturbations to normally functioning biological networks and pathways, the National Heart, Lung, and Blood Institute plans to fund new research project grants that will use a systems biology approach to studying a variety of disorders.

Under a new funding program, NHLBI aims to support multi-disciplinary, collaborative research projects that use experimental and computational approaches to understanding normal physiology and perturbations that are involved in heart, lung, blood, and sleep disorders.

Collaborative teams of researchers from the biomedical, informatics, physical, and mathematical disciplines, which may be headed by multiple principal investigators, will use funding from the Exploratory Program in Systems Biology to develop computational models and perform experiments in a wide range of areas.

Because the nature and scope of the collaborative projects will vary from project to project, the size and duration of the awards will vary.

These systems biology projects may involve a wide range of studies including, but not limited to, research that integrates existing data from genome-wide association and microarray studies with data from the project; integrates imaging and 'omics data to define factors of atherosclerotic plaque vulnerability; develops systems approaches to molecular network features that can categorize disease susceptibility and drug responses; and predicts, validates, and implements biomarker signatures for monitoring drug mechanism of action, drug efficacy, and toxicities.

Go here to see the original:
NHLBI to Fund Collaborative Systems Biology Disease Studies

Raise a glass of wine to resveratrol

Drinkers the world over have been thrilled by the notion that resveratrol, a chemical found in red wine, might be some kind of anti-aging powerhouse.

The supposed wonder substance can make perilously chubby lab rats live as long as their slim counterparts, protect them from cancers and reduce their risk of dying from a high-calorie diet. It can lengthen the life of certain fish while warding off brain decay and improving the creatures' swimming chops.

Which may sound very alluring for those of us who'd like to think that sipping Pinot Noir while relaxing on a couch counts as doing something healthful.

But does what goes for mice and fish go for people too? Well, nobody yet has divided us into two groups, given one group resveratrol, the other a placebo, then checked several decades later to see how long we all lived. But results from a few small human trials show a lot of potential.

A study of 11 obese men, for instance, found that administering 150 milligrams of resveratrol a day for 30 days mimicked the effects of calorie restriction, which has been shown to increase life span.

Another study of 40 patients who'd had heart attacks demonstrated improved cardiac function after participants took 10 milligrams of resveratrol a day for three months.

Still more research has shown that people who took the substance in varying amounts were better able to control their blood sugar.

But here's the catch: To get the doses of resveratrol used in these studies, you'd have to drink between two and 100 bottles of wine a day. "I definitely don't recommend that," says Dr. Jill Crandall, director of the Diabetes Clinical Trial Unit at Albert Einstein College of Medicine. She's not a fan of resveratrol supplements either: "The reliability of suppliers and purity of preparations is not very regulated," she says.

Still, studies do show that a glass or so of red wine a day may be good for the heart (which is why people started looking at the qualities of its ingredients to begin with). "There are many things in red wine that are beneficial to health," says Joseph Baur, assistant professor of physiology at the University of Pennsylvania. The tricky part, he says, is figuring out how much credit each substance is due and how it does what it does. In the meantime, raise your glass in moderation, of course.

health@latimes.com

Excerpt from:
Raise a glass of wine to resveratrol

What is migraine by Dr.Vivek Kumar DM (Neurology) – Video

23-03-2012 01:07 This patient educational video is brought to you by Dr.Vivek Kumar MD DM (Neurology) Sr.Consultant Neurologist, Metro Multispeciality Hospital, Noida. The presentation is based on the clinical experience and the evidences available. Note : Please Consult you doctor before following anything given or spoken in this patient education video.

Follow this link:
What is migraine by Dr.Vivek Kumar DM (Neurology) - Video

Father-to-son sperm donation: 'Too bizarre'?

After three years of trying to conceive, a married couple in the Netherlands in their early 30s learned they could not have a child because the husband produced no sperm. They did not want to use sperm donated from a stranger, partly because this would mean the child would not share genes with the husband's side of the family. But because the husband had no brothers to donate, the couple seemed at a loss on how to pass on his gene pool.

Don't miss these Health stories

They use archery, swiftness and brute strength to compete against each other but, luckily, the participants in these games -- which take place at a gym in New York -- will still be alive at the end of the day.

Then the couple thought of an unconventional solution: Use sperm from the husband's father. The child produced from this union of egg and sperm would have a "father" who was his biological half- brother, and a "grandfather" who was his biological father.

As all parties were comfortable with the decision, the couple went to a fertility clinic with their request. After much deliberation, including a discussion with the hospital ethics committee, the clinic eventually decided to honor the couple's wishes.

Though not common, donations of sperm, egg or womb from family members to couples trying to conceive are not technically illegal, and do happen. Such arrangements have potential advantages over using donations from strangers, but they bring their own set of complications, including potential confusion regarding who the child's parent is, say researchers who detail these complexities in a case report of the Netherlands' couple published online March 7 in the journal Human Reproduction. Experts have varying views on the issue, but most agree so-called intrafamilial assisted reproduction should not necessarily be banned, and can perhaps work in some circumstances. However, any couples who decided to enter this territory should tread carefully, say experts.

"I dont know that laws should encompass forbidding intrafamilial donation," said Adrienne Asch, director of the Center for Ethics at Yeshiva University in New York City. But couples who request it "should be very carefully counseled about the psychological pitfalls that could await them," Asch said.

Ethical problems

Couples may turn to family members to assist with reproduction for many reasons. Some, like the couple in the Netherlands, want to have a genetic tie with their child. Others may wish to cut down on the time and money needed for the procedure, according to a position statement from the American Society for Reproductive Medicine (ASRM).

However, one concern in these situations is that the person who donates will want to act as a parent to the child. In the case of the couple from the Netherlands, the "grandfather" may find it hard to resist inserting himself into the family, said Arthur Caplan, bioethicist at the University of Pennsylvania.

Read the original:
Father-to-son sperm donation: 'Too bizarre'?

Identifying Acute Myeloid Leukemia Gene Mutations May Indicate Risk, Best Treatment

Newswise TAMPA, Fla. (March 23, 2012) An international group of researchers, including those from Moffitt Cancer Center in Tampa, Fla., have published a paper in the March 14 issue of the New England Journal of Medicine reviewing the results of a study that analyzed mutations in 18 genes of 398 patients who had acute myeloid leukemia (AML). They found that several mutated genes predicted improved outcomes when patients with certain gene mutations were given high-dose induction chemotherapy. Their findings suggest that mutational profiling could potentially be used for both risk stratification and also in helping health care providers make therapeutic decisions for some AML patients.

Previous studies have found that AML is a highly heterogenic disorder, said study co-author Hugo F. Fernandez, a senior member at Moffitt and associate chief of Moffitts Blood and Marrow Transplantation Division. Moreover, recent studies have revealed that a number of genetic mutations in AML patients might have prognostic value. The question of the presence of these gene mutations altering outcomes based on current therapy had not been answered to date.

Their paper cites a clinical trial carried out by the Eastern Cooperative Oncology Group (ECOG) in which dose-intensified chemotherapy improved outcomes in two age sets of AML patients. Based on these findings, the research team hypothesized that carrying out mutational analysis of all known molecular alterations occurring in more than 5 percent of patients with AML might allow for the identification of distinct, molecularly defined subgroups of patients who might benefit from dose-intensified chemotherapy.

The laboratory research team subsequently performed a mutational analysis on diagnostic samples from 398 patients enrolled in the ECOG clinical trial they cited and used patients frozen sample cells for extraction and profiling. The researchers validated the results of this latter group of 104 patients.

We found that intensification of the dose of anthracycline significantly improved outcomes and overall survival in patients with mutations in DNMT3A, NPM1 or MLL translocations, said Fernandez. This finding suggests that mutational profiling could be used to determine which AML patients will benefit from dose-intensive induction therapy.

Most importantly, said Fernandez, this study demonstrates how integrated mutational profiling of samples from a clinical trial cohort can advance understanding of the biologic characteristics of AML.

About Moffitt Cancer Center Follow Moffitt on Facebook: http://www.facebook.com/MoffittCancerCenter Follow Moffitt on Twitter: @MoffittNews Follow Moffitt on YouTube: MoffittNews

Located in Tampa, Moffitt Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center, which recognizes Moffitts excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt is also a member of the National Comprehensive Cancer Network, a prestigious alliance of the countrys leading cancer centers, and is listed in U.S. News & World Report as one of Americas Best Hospitals for cancer.

Media release by Florida Science Communications

The rest is here:
Identifying Acute Myeloid Leukemia Gene Mutations May Indicate Risk, Best Treatment

HepatoChem to Present at Early-Stage Life Sciences Technology Conference VIII

MAHWAH, N.J., March 23, 2012 /PRNewswire/ -- HepatoChem, Inc, a chemistry-based technology platform company with a primary focus on metabolite production from bioactive small molecules, and an investment holding of Heartland Bridge Capital, Inc. (OTCBB: HLBC.OB - News), announced that it will present at the Early-Stage Life Sciences Technology Conference VIII at the Merck Research Laboratories in Boston, MA, on April 12, 2012.

The Early-Stage Life Sciences Technology Conference will showcase 20 life sciences technologies developed at the universities, research institutions, and hospitals of Massachusetts and recently formed Massachusetts companies to an audience of angel investors, venture capitalists and corporate investors. http://www.mattcenter.org/lsconf2012/

HepatoChem recently moved to its new laboratory in Beverly, MA. This is an important step for HepatoChem, which is committed to offering unique metabolite production services. This laboratory is part of the NorthShore Biotech Innoventure.

About HepatoChem, Inc

HepatoChem is a chemistry-based technology platform company with a primary focus on metabolite production from bioactive small molecules. Founded by Marc Bazin, previously with Pfizer, Inc., and Prof. John T. Groves, the Hugh Stott Taylor Chair of Chemistry at Princeton University, HepatoChem is dedicated to developing technologies that help pharmaceutical companies improve the quality of drug development pipelines. HepatoChem offers a unique and powerful solution to resolve the traditional lack of rapid and efficient metabolite access in drug discovery. http://www.hepatochem.com

About Heartland Bridge Capital, Inc.

Heartland Bridge Capital, Inc. (OTCBB:HLBC.OB - News) is a public company that, in addition to managing its own operating entities, participates in emerging companies run by exceptionally talented entrepreneurs and operating executives who are dedicated to creating positive change in our world. HLBC functions as an owner, product developer, and investor focused primarily on providing equity, acquisition debt, or bridge financing to emerging high-growth companies and entrepreneurs in the areas of clean energy, waste management, and life sciences. http://www.heartlandbridgecapital.com.

To request an investor packet, or to receive updates on Heartland Bridge Capital register online at http://www.wallstreetnewscast.com/request/hlbc.html

Safe Harbor Notice

Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Heartland Bridge Capital, Inc. cautions that statements made in this news release relating to the investment in HepatoChem, and potential investment in and the business direction of the Company, constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates, and assumptions made by management. Actual results could differ materially from current projections or implied results. Heartland Bridge Capital, Inc. undertakes no obligation to revise these statements following the date of this news release.

Read this article:
HepatoChem to Present at Early-Stage Life Sciences Technology Conference VIII

Galena Biopharma and CytRx Corp Look to Benefit From Accelerated Approval Pathways

NEW YORK, NY--(Marketwire -03/23/12)- Biotechnology stocks continue to be some of the strongest performers in the markets as favorable legislation out of Washington boosts the sector's reach. The iShares NASDAQ Biotechnology Index (IBB) is currently up more than 16 percent year to date, reflecting an uptick in investor sentiment. The Paragon Report examines investing opportunities in the Biotechnology Industry and provides equity research on Galena Biopharma Inc. (NASDAQ: GALE - News) & CytRX Corporation (NASDAQ: CYTR - News). Access to the full company reports can be found at:

http://www.paragonreport.com/GALE http://www.paragonreport.com/CYTR

Earlier this month the Biotechnology Industry Organization applauded the Faster Access to Specialized Treatments (FAST) Act. According to BIO the legislation will modernize the Accelerated Approval pathway to expedite the development of modern, targeted, and personalized therapies for patients suffering from serious and life-threatening diseases.

BIO President and CEO Jim Greenwood says the FAST act will speed access to innovative new therapies and cures to patients living with debilitating and life-threatening diseases such as Parkinson's, Alzheimer's, diabetes and numerous rare diseases for which there is currently no treatment or cure.

The Paragon Report provides investors with an excellent first step in their due diligence by providing daily trading ideas, and consolidating the public information available on them. For more investment research on the biotechnology industry register with us free at http://www.paragonreport.com and get exclusive access to our numerous stock reports and industry newsletters.

Galena Biopharma, Inc., a biotechnology company, engages in discovering, developing, and commercializing innovative therapies addressing unmet medical needs using targeted bio therapeutics. Earlier this week Galena announced that the U.S. Patent and Trademark Office agreed to award it another patent on NeuVax as a treatment for breast cancer. The patent covers the use of NeuVax in women with HER-2 positive breast cancer.

CytRx Corporation, a biopharmaceutical research and development company, engages in the development of human therapeutics, specializing in oncology. The company's net loss for the year ended December 31, 2011 was $14.4 million, or $0.11 per share, which included a recognized gain of $7.9 million on the valuation of warrant derivative liability.

The Paragon Report has not been compensated by any of the above-mentioned publicly traded companies. Paragon Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at http://www.paragonreport.com/disclaimer

Go here to read the rest:
Galena Biopharma and CytRx Corp Look to Benefit From Accelerated Approval Pathways

Targacept and Incyte Corporation — Strong Performers in Strengthening Biotechnology Industry

NEW YORK, NY--(Marketwire -03/23/12)- Biotechnology stocks continue to be some of the strongest performers in the markets as favorable legislation out of Washington boosts the sector's reach. The iShares NASDAQ Biotechnology Index (IBB) is currently up more than 16 percent year to date, reflecting an uptick in investor sentiment. The Paragon Report examines investing opportunities in the Biotechnology Industry and provides equity research on Targacept Inc. (NASDAQ: TRGT - News) & Incyte Corporation (NASDAQ: INCY - News). Access to the full company reports can be found at:

http://www.paragonreport.com/TRGT http://www.paragonreport.com/INCY

Earlier this month the Biotechnology Industry Organization applauded the Faster Access to Specialized Treatments (FAST) Act. According to BIO the legislation will modernize the Accelerated Approval pathway to expedite the development of modern, targeted, and personalized therapies for patients suffering from serious and life-threatening diseases.

BIO President and CEO Jim Greenwood says the FAST act will speed access to innovative new therapies and cures to patients living with debilitating and life-threatening diseases such as Parkinson's, Alzheimer's, diabetes and numerous rare diseases for which there is currently no treatment or cure.

The Paragon Report provides investors with an excellent first step in their due diligence by providing daily trading ideas, and consolidating the public information available on them. For more investment research on the biotechnology industry register with us free at http://www.paragonreport.com and get exclusive access to our numerous stock reports and industry newsletters.

Targacept, Inc., a biopharmaceutical company, engages in the discovery, design, and development of neuronal nicotinic receptors (NNR) therapeutics for the treatment of diseases and disorders of the nervous system. Targacept reported a net loss of $9.8 million for the fourth quarter of 2011, compared to a net loss of $2.2 million for the fourth quarter of 2010.

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs for oncology and inflammation. Total revenues for the quarter ended December 31, 2011, were $28.9 million as compared to $85.9 million for the same period in 2010.

The Paragon Report has not been compensated by any of the above-mentioned publicly traded companies. Paragon Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at http://www.paragonreport.com/disclaimer

Go here to read the rest:
Targacept and Incyte Corporation -- Strong Performers in Strengthening Biotechnology Industry

Raise a glass of wine to resveratrol

Drinkers the world over have been thrilled by the notion that resveratrol, a chemical found in red wine, might be some kind of anti-aging powerhouse.

The supposed wonder substance can make perilously chubby lab rats live as long as their slim counterparts, protect them from cancers and reduce their risk of dying from a high-calorie diet. It can lengthen the life of certain fish while warding off brain decay and improving the creatures' swimming chops.

Which may sound very alluring for those of us who'd like to think that sipping Pinot Noir while relaxing on a couch counts as doing something healthful.

But does what goes for mice and fish go for people too? Well, nobody yet has divided us into two groups, given one group resveratrol, the other a placebo, then checked several decades later to see how long we all lived. But results from a few small human trials show a lot of potential.

A study of 11 obese men, for instance, found that administering 150 milligrams of resveratrol a day for 30 days mimicked the effects of calorie restriction, which has been shown to increase life span.

Another study of 40 patients who'd had heart attacks demonstrated improved cardiac function after participants took 10 milligrams of resveratrol a day for three months.

Still more research has shown that people who took the substance in varying amounts were better able to control their blood sugar.

But here's the catch: To get the doses of resveratrol used in these studies, you'd have to drink between two and 100 bottles of wine a day. "I definitely don't recommend that," says Dr. Jill Crandall, director of the Diabetes Clinical Trial Unit at Albert Einstein College of Medicine. She's not a fan of resveratrol supplements either: "The reliability of suppliers and purity of preparations is not very regulated," she says.

Still, studies do show that a glass or so of red wine a day may be good for the heart (which is why people started looking at the qualities of its ingredients to begin with). "There are many things in red wine that are beneficial to health," says Joseph Baur, assistant professor of physiology at the University of Pennsylvania. The tricky part, he says, is figuring out how much credit each substance is due and how it does what it does. In the meantime, raise your glass in moderation, of course.

health@latimes.com

Read more here:
Raise a glass of wine to resveratrol

Expert wants central bank for cord blood

A nodal public stem-cell bank in India is the need of the hour if blood cancer and thalassaemia patients are to benefit from stem-cell therapy, according to an expert.

"We need an indigenous inventory of 30,000 units of umbilical cord-blood stem-cells, which would enable seven out of 10 patients seeking stem-cell transplant to find a ready match off the shelves," said P. Srinivasan, a pioneer in public cord-blood banking in the country, addressing members of the Ladies Study Group of the Indian Chamber of Commerce on Friday.

Cord blood, also called "placental blood", is the blood remaining in the umbilical cord and placenta following childbirth after the cord is cut, and is routinely discarded with the placenta and umbilical cord as biological waste.

A rich source of stem cells, cord blood can be used to treat over 80 diseases, including certain cancers like leukaemia, breast cancer, blood disorders like thalassaemia major and autoimmune disorders like lupus, multiple sclerosis, Crohn's Disease and rheumatoid arthritis.

Early clinical studies suggest these can even help avert corneal degeneration and restore vision in cases of blindness, help restore proper cardiac function to heart attack sufferers and improve movement in patients with spinal cord injury.

"Since stem-cell matching is highly ethnicity dependent, the chances of an Indian finding a perfect match in a foreign country is a lot less compared to a resource pool of locally-donated units," the former resource person for WHO, now the chairman and managing trustee of Jeevan Blood Bank and Research Centre in Chennai, added.

Even if someone finds a match abroad, the cost of shipping the bag of matching cord blood could be as high as $40,000, as against the Rs 30,000 required for processing and storing one unit indigenously.

Srinivasan felt reaching the critical mass of 30,000 cord-blood units wasn't a big deal, given the fact that 20 million babies are born in India every year.

Purnima Dutta, the president of Ladies Study Group, agreed that raising awareness on the need to donate umbilical cord blood was the key.

"As women and responsible citizens, the onus is on us to spread the word and encourage young couples to come forward and donate cord blood to ensure we can achieve this desired public-bank inventory which can save valuable lives," she said.

Read the original here:
Expert wants central bank for cord blood

Stem Cell Therapy Used To Treat 9/11 Search And Rescue Dog

ANNAPOLIS, Md. (WJZ)One of the last search and rescue dogs from 9/11 lives here in Maryland. She was suffering from a painful condition until her owner took action with breakthrough technology.

Mary Bubala has the story.

Red is a search and rescue dog from Annapolis, but has traveled across the country. Her missions include Hurricane Katrina, the La Plata tornadoes and the Pentagon after 9/11.

They credit them with finding 70 percent of the human remains so that helped a whole lot of those families actually get closure, said Heather Roche, Reds owner.

Sept. 11 was Reds first search. Today shes one of the last 9/11 search and rescue dogs still alive.

She retired last summer due to severe arthritis.

It would be nice if her arthritis, if she felt better, that she could do those kinds of things that she misses, Reds owner said while fighting back tears. Alright I am going to cry.

Roche did some research and found an animal hospital in northern Virginia that uses breakthrough stem cell therapy to treat arthritis in dogs.

The Burke Animal Clinic is one of just a few across the country that use stem cell therapy.

The vet harvests 1 to 2 ounces of the dogs fatty tissue, activates the stem cells and then injects them back into the troubled areas.

See more here:
Stem Cell Therapy Used To Treat 9/11 Search And Rescue Dog

Exercise Has Benefits, Even When It’s Done in Space

Astronauts living on the International Space Station show small effect on cardiovascular health when accompanied by an exercise regimen

Article published in the Journal of Applied Physiology

Newswise BETHESDA, Md. (March 22, 2012)Astronauts have been taking part in short spaceflight missions since 1961. They have only recently begun to spend significantly longer times in space, with missions extending for months, since the days of the Russian Mir space station (1986-2001) and extended stays on the International Space Station (ISS; November 2000). Though earlier studies clearly showed that astronauts on these extended missions suffered serious deficits from lengthy times in a low-gravity environment, including dizziness when standing up, considerable loss of bone mass, and impaired muscle function, little was known about the effects of long-term space flight on the heart and vascular system. In a new study, a research team has tested various cardiovascular measures in six astronauts on long-term missions aboard the International Space Station. These findings show that lengthy spaceflight indeed affects cardiovascular responses, but not as dramatically as the researchers predicted, suggesting that the intensive exercise routines astronauts on these long missions complete every day are doing their job.

The article is entitled Cardiovascular Regulation During Long-Duration Spaceflights to the International Space Station. It appears in the current edition of the Journal of Applied Physiology, published by the American Physiological Society.

Methodology The researchers collected data from six male astronauts, between 41 and 55 years old, who were headed to the ISS on missions ranging from 52 to 199 days. At about a month before they embarked, the research team collected a wealth of data on each subjects cardiovascular health. This data was collected during spontaneous and paced breathing, both sitting up and lying down, to reflect a variety of conditions and cardiovascular stresses. The researchers measured various factors including finger arterial blood pressure, heart rate, left ventricular ejection time, and cardiac output. The astronauts repeated these measures independently a few weeks after they arrived at the space station, then a few weeks before they returned to Earth. A final assessment took place again soon after landing on Earth.

Results Results showed that heart rate, blood pressure, and arterial baroreflex response (the bodys natural way to regulate heart rate and blood pressure based on continuous sensing of both) were unchanged from pre-flight to in-flight. Left ventricular ejection times and cardiac output both increased in-flight, while time between heartbeats, arterial pulse pressure, and the blood pumped from the heart decreased. In the post-flight testing compared to pre-flight measures, heart rate and cardiac output increased slightly, while arterial baroreflex response decreased by about a third, but only in the seated position.

Importance of the Findings These findings suggest that long-duration spaceflight has significant effects on cardiovascular function, yet these effects are relatively small. The researchers attribute this cardiovascular stability to the intensive exercise program astronauts commit to while on lengthy spaceflight missions. On these particular missions, the six astronauts were each allotted 2.5 hours per day to set up for exercise, complete a workout, and clean up after the session, with options to exercise on a cycle, treadmill, or doing resistance training. These exercise sessions appear to keep astronauts relatively healthy and prepared for return to Earth, despite the potentially negative effects of a low-gravity environment.

These post-flight changes were somewhat less than expected based on short-duration flights and early reports of long-duration missions and suggest that the current countermeasures on the ISS, which include exercise training, are keeping cardiovascular control mechanisms well prepared for return to Earth, the authors say.

The ISS astronauts in the current study represent the first six-person crew, signifying the transition to greater possibilities to conduct science on this major international laboratory, they note.

Study Team The study was conducted by R. L. Hughson, D. K. Greaves, P. P. Pereira-Junior, and D. Xu of the University of Waterloo; J.K. Shoemaker of the University of Western Ontario; A. P. Blaber of Simon Fraser University; and P. Arbeille of CERCOM, EFMP CHU Trousseau.

Read more here:
Exercise Has Benefits, Even When It's Done in Space

Pro Shop Nutrition aims to help

Pro Shop Nutrition owner David Park said his business does not make money. The only money this business makes is to regenerate its own products, he said. Park, who has been in the business since 1997, said he has a job teaching the driving-under-the-influence program in Ridgecrest and Mojave, and his wife works for the Sierra Sands Unified School District. This business is put together so people in Ridgecrest dont have to leave to get products from high-priced stores, he said. The business carries weight-loss products, body-building products as well as health and nutrition products for mind and body. You have to work with the whole body, Park said. People want to trim fat or add beef, but its much more than that. He said he can put diet plans together for people who want to lose weight. Asked how the store regenerates its own product, Park said the store sells its own product with enough profit to buy its own product. I have yet to take a paycheck, and Ive been open since December, he said. I dont take money from the store. My wife doesnt take money from the store. Pro Shop Nutrition carries brand names such as BSN, Muscle Tech, Optimum Nutrition, Muscle Pharm, Cellucor, USP Labs and Now. Park said his daughter, Monica, has been in Ridgecrest since third grade. Ive been here every summer and every weekend all my life, he said. When I became an adult, I came to Ridgecrest. I consider myself a Ridgecrest person. This store was put together for Ridgecrest people. He said the business is family-owned and operated, and it is not a franchise. We take a lot of pride in being able to help people, said Park. For example if someone came into my store looking for a specific product that they got out of town and they liked it, we have a suggestion box. We do special orders all the time. The business is open Monday through Friday from 10 a.m. to 7 p.m. and Saturday from 10 a.m. to 4 p.m. The phone number is 760-375-8663, and the business accepts Visa and Mastercard. Were truly here to help people achieve their goals, he said. If a person sees something on the shelf when they walk into my store, I always ask them, What are you looking to do not What are you looking for, and I try to match that product with their goal.

See the original post here:
Pro Shop Nutrition aims to help